---
title: ""
page-layout: full
toc: false
---


```{=html}
<div class="hero-split">
  <div class="column">
    <div class="hero-text">
      <div class="hero-kicker">
        <span class="hero-title">Weldy Lab</span>
        <span class="hero-sep"> | </span>
        <span class="hero-subtitle">Genes · RNA · Hearts · Medicine</span>
      </div>

      <div class="hero-tagline">
        Accelerating precision medicine through epigenetics and RNA editing
      </div>

      <div class="hero-buttons">
        <a class="btn btn-primary" href="research.qmd">Research</a>
        <a class="btn btn-outline-primary" href="people.qmd">People</a>
        <a class="btn btn-outline-secondary" href="join.qmd">Join</a>
      </div>

      <div class="stanford-line">
        <div class="stanford-text">
          Stanford University · Division of Cardiovascular Medicine
        </div>
        <img
          src="images/SUSig_StnfrdOnly_red.png"
          alt="Stanford University"
          class="stanford-logo">
      </div>
    </div>
  </div>

  <div class="column">
    <img
      src="images/WeldyLabLogo.jpg"
      alt="Weldy Lab hero image"
      class="hero-img-split">
  </div>
</div>


```

---

## From genetic discovery to cardiovascular innovation

::: {.text-center}
## Lab Mission

> *The Weldy Lab seeks to transform cardiovascular medicine by integrating human genetics with mechanistic biology to uncover causal pathways of disease and pioneer new therapeutic strategies.*
:::


---

## Featured publications

::: {.columns .v-center}
::: {.column width="30%" .cover-column}
[![](images/MolecularSysBio_Cover.jpg){width=100%}](https://doi.org/10.1038/s44320-025-00140-2)
:::

::: {.column width="70%"}
### Epigenomic landscape of single vascular cells reflects developmental origin and disease risk loci

**Weldy CS**, et al. *Molecular Systems Biology* (2025)  
DOI: 10.1038/s44320-025-00140-2

Single-cell epigenomic profiling reveals how developmental origin shapes vascular cell states and maps aortic dimension and aneurysm risk loci to specific cell type and vascular site specific programs across smooth muscle, endothelial, and fibroblast cell types.

[Read the paper →](https://doi.org/10.1038/s44320-025-00140-2)
:::
:::

::: {.columns .v-center}
::: {.column width="30%" .cover-column}
[![](images/NatCVR_Cover.jpg){width=100%}](https://doi.org/10.1038/s44161-025-00710-5)
:::

::: {.column width="70%"}
### Smooth muscle cell ADAR1 controls activation of RNA sensor MDA5 in atherosclerosis

**Weldy CS**, et al. *Nature Cardiovascular Research* (2025)  
DOI: 10.1038/s44161-025-00710-5

A smooth muscle–specific RNA editing program regulates dsRNA sensing and inflammatory signaling in atherosclerosis, linking RNA biology to vascular disease mechanisms.

[Read the paper →](https://doi.org/10.1038/s44161-025-00710-5)
:::
:::

---

## Areas of focus
- Human genetics & causality
- Vascular biology & site-specific mechanisms
- RNA biology (A-to-I editing) and innate immune sensing
- Single-cell and multi-omics approaches

---

## RNA editing and double-stranded RNA sensing

::: {.columns .v-center}

::: {.column width="60%"}

*RNA editing by ADAR enzymes is a fundamental mechanism that allows cells to distinguish self from non-self RNA.*  

Through A-to-I editing of double-stranded RNA, ADAR1 reshapes endogenous RNA structures and prevents inappropriate activation of the innate immune sensor MDA5 (gene symbol *IFIH1*).

Genetic and molecular studies now show that reduced RNA editing increases inflammatory signaling and disease risk, including coronary artery disease. Our work demonstrates that impaired ADAR1-mediated editing in vascular smooth muscle cells leads to pathologic dsRNA sensing, identifying endogenous RNA recognition as a causal mechanism of vascular disease.

By integrating human genetics, RNA biology, and vascular models, we study how variation in RNA editing and activation of dsRNA sensing programs connects genetic risk to inflammation and cardiovascular pathology.

[Learn more about our RNA editing research →](research.qmd)

:::

::: {.column width="40%"}

![](images/ADARfig.jpg){width=100% style="border-radius:10px;"}
*ADAR1-mediated RNA editing suppresses endogenous dsRNA sensing by MDA5 in vascular cells.*

:::

:::

---

## News
[See lab updates →](news/)

## Featured news
- **Dec 15, 2025:** Stanford CVI highlights how arteries retain a developmental “memory” that shapes disease susceptibility.  
  [Read →](news/2025-12-15-developmental-memory-arteries.html)

- **Nov 16, 2024:** Stanford Medicine highlights our RNA editing work.  
  [Read →](news/2024-11-16-stanford-medicine-rna-editing.html)

## Affiliations

::: {.columns}
::: {.column width="50%"}
![](images/Stanfordlogo.png){style="max-height:110px; width:100%; object-fit:contain;"}
:::
::: {.column width="50%"}
![](images/SOMlogo.png){style="max-height:110px; width:100%; object-fit:contain;"}
:::
:::

::: {.columns}
::: {.column width="50%"}
![](images/CVIlogo.jpeg){style="max-height:110px; width:100%; object-fit:contain;"}
:::
::: {.column width="50%"}
![](images/SCICDlogo.jpg){style="max-height:110px; width:100%; object-fit:contain;"}
:::
:::

## Funding

::: {.columns}
::: {.column width="50%"}
![](images/NIHlogo.png){style="max-height:110px; width:100%; object-fit:contain;"}
:::
::: {.column width="50%"}
![](images/NHLBIlogo.png){style="max-height:110px; width:100%; object-fit:contain;"}
:::
:::

::: {.columns}
::: {.column width="50%"}
![](images/AHAlogo.png){style="max-height:110px; width:100%; object-fit:contain;"}
:::
::: {.column width="50%"}
![](images/SU_Seal_Red.png){style="max-height:110px; width:100%; object-fit:contain;"}
:::
:::
